|
|
||||||||
POINT-COUNTERPOINT COMMENTS
University of Leipzig-Heart Center
Department of Cardiology
Leipzig, Germany
e-mail: linkea{at}medizin.uni-leipzig.de
ABSTRACT
This letter is in response to the Point:Counterpoint series "Flow-mediated dilation does/does not reflect nitric oxide-mediated endothelial function" that appeared in the September issue (vol. 99: 12331238, 2005; doi:10.1152/japplphysiol.00601.2005; http://jap.physiology.org/content/vol99/issue3/2005).
12%) independent of whether the occlusion was performed upstream (upper arm) or downstream (wrist) of the site of measurement (3). Interestingly, the increase in radial artery diameter was even more pronounced after longer periods of vessel occlusion before assessment of FMD (
13% after 8 min vs.
7% after 4 min). The amount of FMD abolished by L-NMMA was
66% in healthy individuals but
33% in patients with chronic heart failure (CHF), possibly due to endothelin-mediated vasoconstriction in CHF (1, 3). Therefore, FMD appears to partially reflect NO-mediated endothelial function. The abovementioned data are consistent with the hypothesis that key players other than NO mediating FMD, e.g., prostaglandins and myogenic factors, in different experimental settings depend on 1) the duration of occlusion, 2) the site of measurement in relation to the site of vessel occlusion, and 3) the subjects, in whom the measurements are performed. REFERENCES
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |